OPPENHEIMER ASSET MANAGEMENT INC. - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
OPPENHEIMER ASSET MANAGEMENT INC. ownership history of BAXTER INTL INC
ValueSharesWeighting
Q3 2023$8,434,286
-2.8%
223,484
+17.3%
0.13%
+0.8%
Q2 2023$8,676,811
+129.7%
190,448
+104.5%
0.13%
+120.7%
Q1 2023$3,777,677
-12.6%
93,138
+9.8%
0.06%
-17.1%
Q4 2022$4,322,562
-10.5%
84,806
-5.4%
0.07%
-17.6%
Q3 2022$4,830,000
-15.5%
89,674
+0.8%
0.08%
-11.5%
Q2 2022$5,713,000
-7.7%
88,943
+11.4%
0.10%
+9.1%
Q1 2022$6,191,000
-3.4%
79,844
+6.9%
0.09%
+3.5%
Q4 2021$6,409,000
-8.1%
74,662
-13.9%
0.08%
-14.1%
Q3 2021$6,973,000
+7.0%
86,696
+7.1%
0.10%
+6.5%
Q2 2021$6,514,000
+1.7%
80,927
+6.6%
0.09%
-6.1%
Q1 2021$6,405,000
+42.3%
75,949
+35.4%
0.10%
+32.0%
Q4 2020$4,500,000
+2.5%
56,085
+2.7%
0.08%
-11.8%
Q3 2020$4,392,000
+44.5%
54,608
+54.6%
0.08%
+34.9%
Q2 2020$3,039,000
+18.0%
35,311
+11.3%
0.06%0.0%
Q1 2020$2,575,000
-3.6%
31,718
-0.7%
0.06%
+12.5%
Q4 2019$2,671,000
-0.7%
31,944
+3.8%
0.06%
-6.7%
Q3 2019$2,691,000
+10.4%
30,761
+3.4%
0.06%
+11.1%
Q2 2019$2,437,000
+19.6%
29,759
+18.8%
0.05%
+17.4%
Q1 2019$2,037,000
+21.0%
25,044
-2.1%
0.05%
+9.5%
Q4 2018$1,683,000
-17.7%
25,576
-3.6%
0.04%
-6.7%
Q3 2018$2,045,000
+19.9%
26,533
+14.8%
0.04%
+7.1%
Q2 2018$1,706,000
+23.3%
23,109
+8.6%
0.04%
+20.0%
Q1 2018$1,384,000
-1.4%
21,278
-4.8%
0.04%
-5.4%
Q4 2017$1,403,0000.0%22,3620.0%0.04%
+2.8%
Q3 2017$1,403,000
+0.9%
22,362
-2.6%
0.04%
-5.3%
Q2 2017$1,390,000
+21.5%
22,966
+4.1%
0.04%
+15.2%
Q1 2017$1,144,00022,0650.03%
Other shareholders
BAXTER INTL INC shareholders Q4 2020
NameSharesValueWeighting ↓
JONES ROAD CAPITAL MANAGEMENT, L.P. 200,000$7,548,0006.60%
BOONE CAPITAL MANAGEMENT LLC 469,405$17,715,3455.59%
Soditic Asset Management LLP 186,920$7,054,3615.43%
JONES ROAD CAPITAL MANAGEMENT, L.P. 131,000$4,943,9404.32%
Camber Capital Management LP 3,000,000$113,2203.73%
Carmignac Gestion 4,848,773$182,991,7183.36%
SHAPIRO CAPITAL MANAGEMENT LLC 3,028,799$114,306,8743.33%
Hillman Capital Management, Inc. 219,248$8,274,4203.19%
Cincinnati Specialty Underwriters Insurance CO 201,500$7,604,6102.90%
Callodine Capital Management, LP 265,000$10,001,1002.79%
View complete list of BAXTER INTL INC shareholders